Search Results - "Gersh, Robert H."

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
  2. 2

    Hematologic Response to Three Alternative Dosing Schedules of Azacitidine in Patients With Myelodysplastic Syndromes by LYONS, Roger M, COSGRIFF, Thomas M, MODI, Sanjiv S, GERSH, Robert H, HAINSWORTH, John D, COHN, Allen L, MCINTYRE, Heidi J, FERNANDO, Indra J, BACKSTROM, Jay T, BEACH, C. L

    Published in Journal of clinical oncology (10-04-2009)
    “…Azacitidine (AZA) is effective treatment for myelodysplastic syndromes (MDS) at a dosing schedule of 75 mg/m(2)/d subcutaneously for 7 days every 4 weeks. The…”
    Get full text
    Journal Article
  3. 3
  4. 4